A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT03598790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Study identification
- NCT ID
- NCT03598790
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Enrollment
- 1,353 participants
Conditions and interventions
Interventions
- Bimekizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 4, 2018
- Primary completion
- Nov 13, 2023
- Completion
- Nov 13, 2023
- Last update posted
- Apr 14, 2026
2018 – 2023
United States locations
- U.S. sites
- 48
- U.S. states
- 25
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ps0014 957 | Glendale | Arizona | 85308 | — |
| Ps0014 946 | Phoenix | Arizona | 85032 | — |
| Ps0014 910 | Bakersfield | California | 93309 | — |
| Ps0014 927 | Los Angeles | California | 90033 | — |
| Ps0014 919 | San Diego | California | 92103 | — |
| Ps0014 955 | San Diego | California | 92123 | — |
| Ps0014 943 | San Luis Obispo | California | 93405 | — |
| Ps0014 967 | Santa Monica | California | 90404 | — |
| Ps0014 934 | Washington D.C. | District of Columbia | 20016 | — |
| Ps0014 909 | Boynton Beach | Florida | 33437 | — |
| Ps0014 912 | Coral Gables | Florida | 33134 | — |
| Ps0014 928 | Fort Myers | Florida | 33912 | — |
| Ps0014 906 | Hollywood | Florida | 33021 | — |
| Ps0014 907 | Miami | Florida | 33144 | — |
| Ps0014 903 | Ocala | Florida | 34470 | — |
| Ps0014 921 | Ormond Beach | Florida | 32174 | — |
| Ps0014 936 | Tampa | Florida | 33613 | — |
| Ps0014 941 | Alpharetta | Georgia | 30022 | — |
| Ps0014 954 | Skokie | Illinois | 60077 | — |
| Ps0014 911 | Plainfield | Indiana | 46168 | — |
| Ps0014 900 | West Des Moines | Iowa | 50265 | — |
| Ps0014 905 | Overland Park | Kansas | 66210 | — |
| Ps0014 962 | Owensboro | Kentucky | 42301 | — |
| Ps0014 922 | Baton Rouge | Louisiana | 70809 | — |
| Ps0014 944 | New Orleans | Louisiana | 70115 | — |
| Ps0014 940 | Beverly | Massachusetts | 01915 | — |
| Ps0014 925 | Brighton | Massachusetts | 02135 | — |
| Ps0014 917 | Troy | Michigan | 48084 | — |
| Ps0014 915 | Clayton | Missouri | 63105 | — |
| Ps0014 958 | Omaha | Nebraska | 68144 | — |
| Ps0014 901 | Portsmouth | New Hampshire | 03801 | — |
| Ps0014 908 | East Windsor | New Jersey | 08520 | — |
| Ps0014 956 | Verona | New Jersey | 07044 | — |
| Ps0014 947 | Buffalo | New York | 14221 | — |
| Ps0014 965 | Kew Gardens | New York | 11415 | — |
| Ps0014 913 | New York | New York | 10029-6501 | — |
| Ps0014 963 | Rochester | New York | 14623 | — |
| Ps0014 961 | Rocky Mount | North Carolina | 27804 | — |
| Ps0014 932 | Oklahoma City | Oklahoma | 73112 | — |
| Ps0014 920 | Portland | Oregon | 97210 | — |
| Ps0014 929 | Portland | Oregon | 97223 | — |
| Ps0014 937 | Johnston | Rhode Island | 02919 | — |
| Ps0014 945 | Greer | South Carolina | 29650 | — |
| Ps0014 931 | Dallas | Texas | 75231 | — |
| Ps0014 924 | Houston | Texas | 77004 | — |
| Ps0014 914 | San Antonio | Texas | 78213 | — |
| Ps0014 951 | Webster | Texas | 77598 | — |
| Ps0014 933 | Murray | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 141 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03598790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03598790 live on ClinicalTrials.gov.